Total income of the company grew 31.71% to Rs 26.54 crore during the quarter, as against Rs 20.15 crore in the corresponding quarter a year ago.
The total expenditure of the company has increased 6.49 % to Rs 24.92 crore in the third quarter, from Rs 23.40 crore in the same quarter last year.
During the last financial year, Vimta Labs had failed to execute projects worth Rs 30 crore due to global economic slowdown and the regulatory approvals in India. The company expects to cross Rs 100 crore revenue mark by end of this financial year, the company told Business Standard earlier this financial year.
Vimta Lab's scrip is currently trading at Rs 20 on BSE, up 5.82% over the previous close of Rs 18.90.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app